Medication For Migraine Chart: Table 1: Acute Treatment when the attack begins

Size: px
Start display at page:

Download "Medication For Migraine Chart: Table 1: Acute Treatment when the attack begins"

Transcription

1 Medication For Migraine Chart: Table 1: Acute Treatment when the attack begins Page a Analgesics (painkillers) Non-steroidal antiinflammatory drugs (NSAIDs) Prescription required Brand Name Formulation type Aspirin No There are many different preparations of analgesics so the brand names are too numerous to mention. enteric coated tablets Ibuprofen No, modified release tablets, suspension, Several combination Diclofenac preparations are available. The most commonly used contain aspirin or paracetamol combined Naproxen with codeine, caffeine and/or an antiemetic. granules, modified release tablets, dispersible tablets, injection, suppositories, enteric coated tablets Tolfenamic acid Clotam rapid tablets Combinations specifically Flurbiprofen licensed for migraine, modified release include: tablets, suppositories Other Paracetamol No Migraleve - OTC, soluble tablets, Pink tablets codeine, capsules, suppositories, paracetamol & suspension Codeine phosphate Depends on formulation (may buclizine, injection, syrup be OTC when combined with Yellow tablets - aspirin or paracetamol codeine & paracetamol Paramax - POM Paracetamol & metoclopramide, dispersible tablets, suppositories, Combinations also available as dispersible tablets, tablets, capsules, sachets Analgesic drugs relieve pain and reduce stiffness associated with migraine. The NSAIDs also reduce inflammation by inhibiting the production of certain chemicals in the body. Analgesics tend to be more effective when taken as soluble, effervescent or liquid formulations because they are absorbed quicker (not all drugs are available in these forms). Enteric coated preparations are less suitable for treating migraine attacks because they are absorbed more slowly and therefore may take longer to work Codeine is an analgesic which blocks pain signals in the spinal cord and brain Caffeine is a weak stimulant that is often combined in small amounts with analgesics to enhance their effect. However, there is evidence that caffeine can provoke headache and may result in headaches following its withdrawal after long term treatment POM Prescription only medication OTC- over the counter - registered. Enteric coated - tablets can be coated with a substance that enables them to pass through the stomach and into the intestine unchanged

2 Table 1: Acute continued Page b Antiemetics (Antisickness) Domperidone Some preparations are OTC Generic form Motilium OTC Metoclopramide Generic form Maxolon Maxolon SR Paramax Metoclopramide combined with paracetamol MigraMax Metoclopramide combined with aspirin Prochlorperazine Generic, suppositories, suspension, Solution, injection, Syrup, injection Capsules ; Sachets containing effervescent powder Sachets containing powder Anti-emetics relieve the nausea associated with migraine attacks. Metoclopramide and domperidone also promote normal activity of the gut and can accelerate the absorption of analgesics Anti-emetics should be taken before or at the same time as analgesics Metoclopramide is associated with serious side effects (resulting in symptoms very like Parkinson s disease) and should be avoided in children and young adults Phenothiazines Buccastem Stemetil Buccal tablets (dissolve in the mouth), syrup, effervescent granules, injection, suppositories

3 Table 1: Acute continued Page c Serotonin (5-HT 1 ) agonists or Triptans Generic Name [the name of the basic active Sumatriptan Prescription required (POM), tablets available on prescription and OTC after assessment by pharmacist Brand Name Formulation type Imigran, injection, nasal spray Selective 5-HT 1 agonists relieve pain by narrowing blood vessels Almotriptan Almogran Eletriptan Relpax Frovatriptan Migard Naratriptan Naramig Rizatriptan Maxalt, Maxalt Melt, wafers Zolmitriptan Zomig Zomig rapimelt Ergot Alkaloids Ergotamine tartrate Cafergot Ergotamine and caffeine Migril Ergotamine, cyclizine and caffeine, nasal spray Wafers (Medihaler discontinued) in the head and blocking the transmission of pain in sensory nerves supplying the skin and structures of the face. Sumatriptan has been available for the longest period of time and is often compared to the newer triptans in trials. If one triptan doesn t work for you then it is worth trying a different one. The BNF states: the value of ergotamine for migraine is limited by difficulties in absorption and by its side effects particularly nausea, vomiting, abdominal pain and muscle cramps. It is best avoided. Recommended doses of ergotamine preparations should NOT be exceeded and treatment should not be repeated at intervals of less than 4 days. To avoid tolerance, the frequency should be limited to no more than twice a month. Patients should be warned to stop treatment if numbness or tingling of the extremities develops. It is most effective if taken at the onset of a migraine attack. BNF British National Formulary is the joint publication published by the British Medical Association and the Royal Pharmaceutical Society which is distributed to NHS doctors by the Department of Health.

4 Table 1: Acute continued Page d Other Isometheptene mucate - also OTC packs of 15 and under may be sold under the supervision of the pharmacist Midrid Isometheptene with paracetamol Capsules Acts by constricting blood vessels in the head and the rest of the body. The BNF state that as more effective preparations are now available it is not widely used. Table 2: Prophylactic treatment to prevent an attack Beta-blockers Propranolol Generic form and several brands available Anti-serotonergic (Anti 5- HT) drugs Metoprolol Generic form Betaloc Lopressor Atenolol Generic form Tenormin, capsules, solution (Modified release available) (Modified release also available) Nadolol Corgard Timolol Betim Pizotifen Generic form Sanomigran, Elixir Methysergide Deseril This is a semi synthetic ergot alkaloid. It should only be administered under hospital supervision because of the side effects (retroperitoneal fibrosis and fibrosis of heart values and pleura). These drugs have several actions: They block or prevent the dilation (widening) of arterial blood vessels in the body They reduce activity of the brain cells involved in migraine Serotonin (5-HT) is a chemical occurring in the body, which is thought to play a key role in migraine. These drugs block 5-HT 2 receptors to stop the effects of 5-HT. Pizotifen also has antihistamine properties and is related to the Tricyclic antidepressants.

5 Table 2: Prophylactic continued Page e Tricyclic antidepressants (TCAs) Anti-convulsants Amitriptyline Dosulepin (Dothiepin) Generic form Generic form Prothiaden, oral solution Capsules, tablets Capsules, tablets These drugs are primarily used for depression, however, they are also effective at preventing Nortriptyline Allegron migraine Serotonin (5-HT) is a chemical occurring in the body, which is thought to play a key role in migraine. TCAs are thought to: Block the re-uptake of 5- HT May block 5-HT 2 receptors The products shown are most commonly used for the prevention of migraine. Sodium valproate Topiramate Generic form Epilim Epilim chrono Topamax, solution, syrup, liquid Gabapentin Neurotonin, capsules NSAIDs Naproxen Generic form Naprosyn Synflex, enteric coated Mode of action in migraine is unclear. They may reduce the capacity of the nerves to transmit pain signals in the brain. See above BNF British National Formulary is the joint publication published by the British Medical Association and the Royal Pharmaceutical Society which is distributed to NHS doctors by the Department of Health.

6 Table 2: Prophylactic continued Page f Calcium channel blockers (calcium channel antagonists) Anti-histamines Centrally acting antihypertensive drug Flunarizine This is not widely available in the UK and is usually only prescribed by a specialist. Cyproheptadine hydrochloride Sibelium Reduces calcium entry into neurons making them less excitable. Blocks dopamine receptors in the brain No Periactin Anti-histamine with 5-HT antagonist and calcium channel blocking activity. Mode of action is unclear Clonidine Dixarit Licensed for hypertension but has been used for migraine. Controlled trials show it is not effective for migraine. The BNF states that this drug is not recommended and may aggravate depression or produce insomnia. Caution: For a small percentage of people with headache, frequent use of drugs particularly ergotamine, triptans, codeine, paracetamol, NSAIDs and caffeine have been implicated in chronic daily headache and rebound headache. If you are experiencing 4 or more migraine attacks per month you should consider the use of preventative treatment to avoid attacks. The information in this fact sheet has been read and checked for accuracy and relevance by headache professionals and people living with migraine. Date reviewed January 2012.

Treatments for migraine

Treatments for migraine Treatments for migraine Information for patients and carers Department of Neurology Aberdeen Royal Infirmary Contents Page About this leaflet Abortive medication for migraine Painkillers Antisickness medication

More information

Management of headache

Management of headache Management of headache TJ Steiner Imperial College London Based on European principles of management of common headache disorders TJ Steiner, K Paemeleire, R Jensen, D Valade, L Savi, MJA Lainez, H-C Diener,

More information

ADVANCES IN MIGRAINE MANAGEMENT

ADVANCES IN MIGRAINE MANAGEMENT ADVANCES IN MIGRAINE MANAGEMENT Joanna Girard Katzman, M.D.MSPH Assistant Professor, Dept. of Neurology Project ECHO, Chronic Pain Program University of New Mexico Outline Migraine throughout the decades

More information

How do we treat migraine? New SIGN Guidelines

How do we treat migraine? New SIGN Guidelines How do we treat migraine? New SIGN Guidelines Managing your migraine Migraine Trust, Edinburgh 2018 Callum Duncan Consultant Neurologist Aberdeen Royal Infirmary Chair SIGN Guideline 155 Premonitory Mood

More information

Chapter 4 ~ Central nervous system

Chapter 4 ~ Central nervous system Chapter 4 ~ Central Nervous System: General Section 1 of 6 Chapter 4 ~ Central nervous system 4.1 Hypnotics and anxiolytics 4.1.1 Hypnotics CHLORAL HYDRATE CLOMETHIAZOLE NITRAZEPAM TEMAZEPAM TRICLOFOS

More information

Current treatment options in the management of migraine Manuela Fontebasso MB ChB

Current treatment options in the management of migraine Manuela Fontebasso MB ChB Drug review Migraine Current treatment options in the management of migraine Manuela Fontebasso MB ChB Skyline Imaging Ltd A range of effective drug therapies is now available to treat and prevent migraine.

More information

HMFP Comprehensive Headache Center Department of Anesthesia, Critical Care and Pain Medicine Beth Israel Deaconess Medical Center Instructor in

HMFP Comprehensive Headache Center Department of Anesthesia, Critical Care and Pain Medicine Beth Israel Deaconess Medical Center Instructor in HMFP Comprehensive Headache Center Department of Anesthesia, Critical Care and Pain Medicine Beth Israel Deaconess Medical Center Instructor in Anesthesia and Neurology Harvard Medical School Limited time

More information

Abortive Agents. Available Strengths. Formulary Limits. Tablet: 5mg, 10mg ODT: 5mg, 10 mg 25mg, 50mg, 100mg. 5mg/act, 20mg/act

Abortive Agents. Available Strengths. Formulary Limits. Tablet: 5mg, 10mg ODT: 5mg, 10 mg 25mg, 50mg, 100mg. 5mg/act, 20mg/act MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY: Migraine Therapy P&T DATE: 9/12/2017 CLASS: Neurological Disorders REVIEW HISTORY 12/16, 9/15, 2/15, 2/10, 5/07 LOB: MCL

More information

Triptan Quantity Limit

Triptan Quantity Limit *- Florida Healthy Kids Triptan Quantity Limit Override(s) Quantity Limit Approval Duration 1 year Oral Tablets Axert (almotriptan) tablets Relpax (eletriptan) tablets 6 tablets (6.25 mg) 12 tablets (12.5

More information

Migraine Management. Jane Melling Headache nurse Mater Misericordiae Hospital

Migraine Management. Jane Melling Headache nurse Mater Misericordiae Hospital Migraine Management Jane Melling Headache nurse Mater Misericordiae Hospital Migraine facts Among the most common disorders of the nervous system 3 rd most prevalent medical disorder on the planet (lancet

More information

Short Clinical Guidelines: Headache, Key Points for Diagnosis and Treatment

Short Clinical Guidelines: Headache, Key Points for Diagnosis and Treatment Clinical Highlights 1. Headache is diagnosed by history and physical examination with limited need for imaging or laboratory tests. 2. Warning signs of possible disorder other than primary headache are:

More information

Diagnosis Isabelle Farrugia B.Pharm.(Hons.),M.S.(UIC) Completion of Assessment Questions following this article

Diagnosis Isabelle Farrugia B.Pharm.(Hons.),M.S.(UIC) Completion of Assessment Questions following this article Management of Migraine Isabelle Farrugia B.Pharm.(Hons.),M.S.(UIC) Completion of Assessment Questions following this article entitles members to one credit towards C.E. requirement. Migraine is a complex

More information

Management options for Migraine. Prof. Dr. Khwaja Nazimuddin Head Dept. of Internal Medicine BIRDEM

Management options for Migraine. Prof. Dr. Khwaja Nazimuddin Head Dept. of Internal Medicine BIRDEM Management options for Migraine Prof. Dr. Khwaja Nazimuddin Head Dept. of Internal Medicine BIRDEM Assessment The Migraine Disability Assessment Score MIDAS Complete loss of work Partial loss of work Off

More information

Clinical Policy: Triptans Reference Number: CP.CPA.217 Effective Date: Last Review Date: Line of Business: Commercial

Clinical Policy: Triptans Reference Number: CP.CPA.217 Effective Date: Last Review Date: Line of Business: Commercial Clinical Policy: Reference Number: CP.CPA.217 Effective Date: 11.16.16 Last Review Date: 11.17 Line of Business: Commercial Revision Log See Important Reminder at the end of this policy for important regulatory

More information

COMBINATION THERAPIES PREVENTATIVE THERAPIES BETA BLOCKERS

COMBINATION THERAPIES PREVENTATIVE THERAPIES BETA BLOCKERS ACUTE THEAPIES TIPTANS TICYCLIC ANTIDEPESSANTS When starting acute treatment, healthcare professionals should warn patients about the risk of developing medication-overuse headache. ASPIIN Aspirin (900

More information

Vestibular Migraine. Information for patients and carers. Department of Neurology and Otolaryngology Aberdeen Royal Infirmary

Vestibular Migraine. Information for patients and carers. Department of Neurology and Otolaryngology Aberdeen Royal Infirmary Vestibular Migraine Information for patients and carers Department of Neurology and Otolaryngology Aberdeen Royal Infirmary What is vestibular migraine? Migraine is a disabling headache disorder that affects

More information

ABORTIVE AGENTS. Average cost per 30 days. Form Limits SEROTONIN AGONISTS $ $ Reserved for treatment failure to either Sumatriptan PA; QL

ABORTIVE AGENTS. Average cost per 30 days. Form Limits SEROTONIN AGONISTS $ $ Reserved for treatment failure to either Sumatriptan PA; QL MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY: Migraine Therapy P&T DATE: 12/11/2018 CLASS: Neurological Disorders REVIEW HISTORY 9/17, 12/16, 9/15, 2/15, 2/10, LOB: MCL

More information

Goals. Primary Headache Syndromes. One-Year Prevalence of Common Headache Disorders

Goals. Primary Headache Syndromes. One-Year Prevalence of Common Headache Disorders Goals One-Year Prevalence of Common Headache Disorders Impact of primary headache syndromes Non pharmacologic Rx of migraine individualized to patient triggers Complementary and alternative Rx of migraine

More information

MIGRAINE UPDATE. Objectives & Disclosures. Learn techniques used to diagnose headaches. Become familiar with medications used for headache treatment.

MIGRAINE UPDATE. Objectives & Disclosures. Learn techniques used to diagnose headaches. Become familiar with medications used for headache treatment. MIGRAINE UPDATE Karen L. Bremer, MD November 16, 2018 Objectives & Disclosures Learn techniques used to diagnose headaches. Become familiar with medications used for headache treatment. Disclosure: I am

More information

Migraine. What are the symptoms of a migraine attack?

Migraine. What are the symptoms of a migraine attack? Migraine Migraine causes attacks of headaches, often with feeling sick or vomiting. Treatment options include: avoiding possible 'triggers', painkillers, antiinflammatory painkillers, anti-sickness medicines,

More information

Clinical Policy: Triptans Reference Number: CP.HNMC.217 Effective Date: Last Review Date: Line of Business: Medicaid Medi-Cal

Clinical Policy: Triptans Reference Number: CP.HNMC.217 Effective Date: Last Review Date: Line of Business: Medicaid Medi-Cal Clinical Policy: Reference Number: CP.HNMC.217 Effective Date: 11.16.16 Last Review Date: 11.17 Line of Business: Medicaid Medi-Cal Revision Log See Important Reminder at the end of this policy for important

More information

Acute Migraine Treatment: What you and your family should know to help you make the best choices with your doctor

Acute Migraine Treatment: What you and your family should know to help you make the best choices with your doctor Acute Migraine Treatment: What you and your family should know to help you make the best choices with your doctor TAKE CONTROL OF YOUR MIGRAINES! ABOUT THIS PATIENT GUIDE: Migraine attacks are often debilitating

More information

Migraine Treatment What you need to know

Migraine Treatment What you need to know Migraine Treatment What you need to know DR NICOLE LIMBERG ST ANDREWS PLACE SPRING HILL www.migrainespecialist.com.au Migraine what is it? Primary neurobiological condition Waves of reduced brain activity

More information

Faculty Disclosure. Karen L. Bremer, MD. Dr. Bremer has listed no financial interest/arrangement that would be considered a conflict of interest.

Faculty Disclosure. Karen L. Bremer, MD. Dr. Bremer has listed no financial interest/arrangement that would be considered a conflict of interest. Faculty Disclosure Karen L. Bremer, MD Dr. Bremer has listed no financial interest/arrangement that would be considered a conflict of interest. HEADACHE UPDATE Karen L. Bremer, MD November 10, 2017 karen.bremer@creighton.edu

More information

Migrainous headache, the menstrual cycle and pregnancy. Dr Manuela Fontebasso Headache Specialist, Author and Headache Education Facilitator

Migrainous headache, the menstrual cycle and pregnancy. Dr Manuela Fontebasso Headache Specialist, Author and Headache Education Facilitator Migrainous headache, the menstrual cycle and pregnancy Dr Manuela Fontebasso Headache Specialist, Author and Headache Education Facilitator What sort of headaches? Migraine with and without aura Tension

More information

Strategies in Migraine Care

Strategies in Migraine Care Strategies in Migraine Care Julie L. Roth, MD Rhode Island Hospital Assistant Professor, Neurology The Warren Alpert Medical School of Brown University March 28, 2015 Financial Disclosures None. Objectives

More information

ONZETRA XSAIL (sumatriptan) nasal powder

ONZETRA XSAIL (sumatriptan) nasal powder ONZETRA XSAIL (sumatriptan) nasal powder Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Pharmacy

More information

SIGN on the pharmacological management of migraine

SIGN on the pharmacological management of migraine GUIDELINES SIGN on the pharmacological management of migraine STEVE CHAPLIN In February 2018, the Scottish Intercollegiate Guidelines Network (SIGN) published a new guideline on the pharmacological management

More information

Maternity. Migraine in pregnancy Information for women

Maternity. Migraine in pregnancy Information for women Maternity Migraine in pregnancy Information for women You have been given this leaflet as you have a diagnosis of migraines. It contains advice to help you manage your migraines safely during your pregnancy.

More information

SUMAVEL DOSEPRO (sumatriptan succinate) solution for injection

SUMAVEL DOSEPRO (sumatriptan succinate) solution for injection SUMAVEL DOSEPRO (sumatriptan succinate) solution for injection Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit

More information

COLUMBIA UNIVERSITY HEADACHE CENTER: NEW PATIENT QUESTIONNAIRE

COLUMBIA UNIVERSITY HEADACHE CENTER: NEW PATIENT QUESTIONNAIRE COLUMBIA UNIVERSITY HEADACHE CENTER: NEW PATIENT QUESTIONNAIRE HEADACHE CHARACTERISTICS Frequency and Severity 1. At what AGE did you get your first headache, of ANY kind? 2. At what AGE did your headaches

More information

Case Presentation. Case Presentation. Case Presentation. Truths about Headaches (2017) Most headaches were muscle-tension headaches

Case Presentation. Case Presentation. Case Presentation. Truths about Headaches (2017) Most headaches were muscle-tension headaches Agenda Case presentation Migraine Morphology Primary and Premonitory Phase Secondary Headache Aura Headache Primer on Pain Medication Overuse Headache Case Presentation RT is a 25 year old woman with daily

More information

Adult & Pediatric Patients. Stanford Health Care, Division Pain Medicine

Adult & Pediatric Patients. Stanford Health Care, Division Pain Medicine Acute Treatment Strategies in Adult & Pediatric Patients Theresa Mallick Searle, MS, RN BC, ANP BC Disclosures Speakers Bureau: Allergan, Depomed Acute Treatment Strategies in Adult & Pediatric Patients

More information

tablet/capsule Paracetamol 500mg

tablet/capsule Paracetamol 500mg Formulary Item Restrictions and/or Advice Non-opioid analgesics + compound analgesic preparations Aspirin 75mg dispersible Aspirin 300mg dispersible Aspirin 300mg Aspirin 75mg EC Paracetamol 500mg / Paracetamol

More information

Update on Diagnosis and Management of Migraines

Update on Diagnosis and Management of Migraines Update on Diagnosis and Management of Migraines Joel J. Heidelbaugh, MD, FAAFP, FACG Clinical Professor Departments of Family Medicine and Urology University of Michigan Learning Objectives To distinguish

More information

Disclosures. Triptans for Kids 5/16/13

Disclosures. Triptans for Kids 5/16/13 5/16/13 Disclosures Triptans for Kids Amy A. Gelfand, MD GelfandA@neuropeds.ucsf.edu Departments of Neurology and Pediatrics UCSF Child Neurology and Headache Center I receive grant funding from: NIH/NINDS

More information

Anti-Migraine Agents

Anti-Migraine Agents DRUG POLICY BENEFIT APPLICATION Anti-Migraine Agents Benefit determinations are based on the applicable contract language in effect at the time the services were rendered. Exclusions, limitations or exceptions

More information

Triptans Quantity Limit Program Summary

Triptans Quantity Limit Program Summary Triptans Quantity Limit Program Summary FDA APPROVED INDICATIONS AND DOSAGE 1-13,14,23,24 Agents Amerge (naratriptan) 1, 2.5 tablets Axert (almotriptan) 6.25, 12.5 tablets migraine attacks with/without

More information

Treatment of Primary Headache Syndromes

Treatment of Primary Headache Syndromes Presenter Disclosure Information 2:45 3:45pm Treatment of Primary Headache Syndromes SPEAKER Gerald W. Smetana, MD The following relationships exist related to this presentation: Gerald W.Smetana, MD,

More information

Faculty Disclosures. Learning Objectives. Acute Treatment Strategies

Faculty Disclosures. Learning Objectives. Acute Treatment Strategies WWW.AMERICANHEADACHESOCIETY.ORG Acute Treatment Strategies Content developed by: Lawrence C. Newman, MD, FAHS Donna Gutterman, PharmD Faculty Disclosures LAWRENCE C. NEWMAN, MD, FAHS Dr. Newman has received

More information

Page: 1 of 6. Aimovig (erenumab-aooe) injection, Ajovy (fremanezumab-vfrm) injection, Emgality (galcanezumab-gnim)

Page: 1 of 6. Aimovig (erenumab-aooe) injection, Ajovy (fremanezumab-vfrm) injection, Emgality (galcanezumab-gnim) Page: 1 of 6 Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Last Review Date: November 30, 2018 Description Aimovig (erenumab-aooe) injection, Ajovy (fremanezumab-vfrm)

More information

Medicines Formulary BNF Section 4 Central Nervous System

Medicines Formulary BNF Section 4 Central Nervous System Medicines BNF Section 4 4.1 Hypnotics and anxiolytics Chloral Hydrate 500mg/5ml Solution Clomethiazole 192mg Capsules Lormetazepam Tablets Melatonin Capsules Nitrazepam Suspension Nitrazepam Tablets Temazepam

More information

Dubai Standards of Care (Migraine)

Dubai Standards of Care (Migraine) Dubai Standards of Care 2018 (Migraine) Preface Migraine is one of the most common problem dealt with in daily practice. In Dubai, the management of migraine is done through various different strategies.

More information

Acute Migraine Treatment in Adults

Acute Migraine Treatment in Adults PL Detail-Document #301104 This PL Detail-Document gives subscribers additional insight related the Recommendations published in PHARMACIST S LETTER / PRESCRIBER S LETTER November 2014 Acute Migraine Treatment

More information

Sumatriptan Tablets, Nasal Spray (Imitrex), Nasal Powder (Onzetra Xsail), sumatriptan and naproxen sodium (Treximet tablets)

Sumatriptan Tablets, Nasal Spray (Imitrex), Nasal Powder (Onzetra Xsail), sumatriptan and naproxen sodium (Treximet tablets) Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 0 Subject: Sumatriptan Page: 1 of 6 Last Review Date: November 30, 2018 Sumatriptan Description Sumatriptan

More information

Sumatriptan Tablets, Nasal Spray (Imitrex), Nasal Powder (Onzetra Xsail), sumatriptan and naproxen sodium (Treximet tablets)

Sumatriptan Tablets, Nasal Spray (Imitrex), Nasal Powder (Onzetra Xsail), sumatriptan and naproxen sodium (Treximet tablets) Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 05.70.10 Subject: Sumatriptan Page: 1 of 6 Last Review Date: March 16, 2018 Sumatriptan Description Sumatriptan

More information

How could I be having migraine when I don't have a headache?

How could I be having migraine when I don't have a headache? Migraine Your doctor thinks you may have migraine. Classic migraine attacks start with visual symptoms (often zig-zag colored lights or flashes of light expanding to one side over 10-30 minutes) followed

More information

Maxalt. Maxalt / Maxalt-MLT (rizatriptan) Description. Section: Prescription Drugs Effective Date: April 1, 2016

Maxalt. Maxalt / Maxalt-MLT (rizatriptan) Description. Section: Prescription Drugs Effective Date: April 1, 2016 Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Maxalt Page: 1 of 5 Last Review Date: March 18, 2016 Maxalt Description Maxalt / Maxalt-MLT (rizatriptan)

More information

Clinical Policy: Triptans Reference Number: CP.CPA.217 Effective Date: Last Review Date: Line of Business: Commercial

Clinical Policy: Triptans Reference Number: CP.CPA.217 Effective Date: Last Review Date: Line of Business: Commercial Clinical Policy: Reference Number: CP.CPA.217 Effective Date: 11.16.16 Last Review Date: 11.18 Line of Business: Commercial Revision Log See Important Reminder at the end of this policy for important regulatory

More information

Sumatriptan Tablets, Nasal Spray (Imitrex), Nasal Powder (Onzetra Xsail), sumatriptan and naproxen sodium (Treximet tablets)

Sumatriptan Tablets, Nasal Spray (Imitrex), Nasal Powder (Onzetra Xsail), sumatriptan and naproxen sodium (Treximet tablets) Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 05.70.10 Subject: Sumatriptan Page: 1 of 5 Last Review Date: December 2, 2016 Sumatriptan Description Sumatriptan

More information

OH, MY ACHING HEAD! I HAVE NO DISCLOSURES OR CONFLICTS OF INTERESTS TO DECLARE MANAGING HEADACHE IN THE OUTPATIENT SETTING SECONDARY HEADACHES

OH, MY ACHING HEAD! I HAVE NO DISCLOSURES OR CONFLICTS OF INTERESTS TO DECLARE MANAGING HEADACHE IN THE OUTPATIENT SETTING SECONDARY HEADACHES 1 JUSTIN A. OSSMAN, MD CHATTANOOGA FAMILY MEDICINE UPDATE OH, MY ACHING HEAD! MANAGING HEADACHE IN THE OUTPATIENT SETTING 2 I HAVE NO DISCLOSURES OR CONFLICTS OF INTERESTS TO DECLARE OBJECTIVES International

More information

Regulatory Status FDA approved indication: Migranal Nasal Spray is indicated for the acute treatment of migraine headaches with or without aura (1).

Regulatory Status FDA approved indication: Migranal Nasal Spray is indicated for the acute treatment of migraine headaches with or without aura (1). Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.60 Subject: Migranal Nasal Spray Page: 1 of 5 Last Review Date: November 30, 2018 Migranal Nasal Spray

More information

Clinical Policy: Sumatriptan Reference Number: CP.CPA.260 Effective Date: Last Review Date: Line of Business: Commercial

Clinical Policy: Sumatriptan Reference Number: CP.CPA.260 Effective Date: Last Review Date: Line of Business: Commercial Clinical Policy: Reference Number: CP.CPA.260 Effective Date: 11.16.16 Last Review Date: 11.17 Line of Business: Commercial Revision Log See Important Reminder at the end of this policy for important regulatory

More information

Migraine is a primary headache disorder ... REPORTS... Migraine: Diagnosis, Management, and New Treatment Options

Migraine is a primary headache disorder ... REPORTS... Migraine: Diagnosis, Management, and New Treatment Options ... REPORTS... Migraine: Diagnosis, Management, and New Treatment Options R. Michael Gallagher, DO; and F. Michael Cutrer, MD Abstract Objective: The safety and tolerability of medications used to treat

More information

Reducing the impact of migraine in the workplace

Reducing the impact of migraine in the workplace Reducing the impact of migraine in the workplace Exeter NHS Headache Clinic, St Thomas Health Centre, Exeter. The objective of this leaflet is to: Confirm a likely diagnosis of migraine. Outline the causes

More information

Zomig. Zomig / Zomig-ZMT (zolmitriptan) Description

Zomig. Zomig / Zomig-ZMT (zolmitriptan) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.22 Subject: Zomig Page: 1 of 5 Last Review Date: November 30, 2018 Zomig Description Zomig / Zomig-ZMT

More information

Zomig. Zomig / Zomig-ZMT (zolmitriptan) Description

Zomig. Zomig / Zomig-ZMT (zolmitriptan) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.22 Subject: Zomig Page: 1 of 5 Last Review Date: March 16, 2018 Zomig Description Zomig / Zomig-ZMT

More information

ASEBP and ARTA TARP Drugs and Reference Price by Categories

ASEBP and ARTA TARP Drugs and Reference Price by Categories ASEBP Pantoprazole Sodium 40 mg (generic) $0.2016 ASEBP Dexlansoprazole 30 mg Dexlansoprazole 60 mg Esomeprazole 10 mg Esomeprazole 20 mg Esomeprazole 40 mg Lansoprazole 15 mg Lansoprazole 30 mg Omeprazole

More information

~ ColumbiaDoctors Adult New Patient Intake Form Patient Information

~ ColumbiaDoctors Adult New Patient Intake Form Patient Information ~ ColumbiaDoctors Adult New Patient Intake Form Patient Information Last Name: First Name: DOB: Gender: Home Phone: Mobile Phone: ---------- Preferred Phone: Home or Mobile (circle one) Email: -----------

More information

2008 Migraine Update Migraine Update Migraine Update. Epidemiology. Yousef Mohammad MD., MSc. Epidemiology

2008 Migraine Update Migraine Update Migraine Update. Epidemiology. Yousef Mohammad MD., MSc. Epidemiology 2008 Migraine Update Yousef Mohammad MD., MSc Assistant Professor of Neurology Ohio State University Medical Center 2008 Migraine Update Epidemiology 2008 Migraine Update Epidemiology Abortive Treatment

More information

TREXIMET UTILIZATION MANAGEMENT CRITERIA

TREXIMET UTILIZATION MANAGEMENT CRITERIA TREXIMET UTILIZATION MANAGEMENT CRITERIA DRUG CLASS: BRAND (generic) NAME: 5HT1 agonists Treximet (sumatriptan/naproxen sodium) 85 mg / 500 mg tablet FDA INDICATIONS: Sumatriptan/naproxen is indicated

More information

Manging Migraine in Children & Adults

Manging Migraine in Children & Adults Manging Migraine in Children & Adults Heather Sim, Chief Executive heather.sim85@gmail.com RCN School Nurses Conference August 2017 1 What are migraines and what triggers them? How do migraines affect

More information

21 st June BDS BASHD Therapeutics Pain and Analgesia. BASHD Therapeutics Analgesics and Pain Management. Links to other BASHD content

21 st June BDS BASHD Therapeutics Pain and Analgesia. BASHD Therapeutics Analgesics and Pain Management. Links to other BASHD content Volume of Prescribing by Dentists 2011 ( a reminder) BASHD Therapeutics Analgesics and Pain Management Analgesics account for 1 in 80 dental prescriptions made A lot more analgesics will be suggested for

More information

What You Should Know About Your HEADACHE. Learn more about headache types, triggers, and treatments, when to get help, and how to help yourself

What You Should Know About Your HEADACHE. Learn more about headache types, triggers, and treatments, when to get help, and how to help yourself What You Should Know About Your HEADACHE Learn more about headache types, triggers, and treatments, when to get help, and how to help yourself Introduction The purpose of this brochure is to give you a

More information

CYCLIC VOMITING SYNDROME. C. Prakash Gyawali, MD Professor of Medicine Washington University in St. Louis

CYCLIC VOMITING SYNDROME. C. Prakash Gyawali, MD Professor of Medicine Washington University in St. Louis CYCLIC VOMITING SYNDROME C. Prakash Gyawali, MD Professor of Medicine Washington University in St. Louis Case 26 year old male Symptoms began at age 19 yr 5-6 day episodes of recurrent, severe vomiting

More information

Package leaflet: Information for the user. Sumatriptan Amneal 100 mg tablets. sumatriptan

Package leaflet: Information for the user. Sumatriptan Amneal 100 mg tablets. sumatriptan Package leaflet: Information for the user Sumatriptan Amneal 50 mg tablets Sumatriptan Amneal 100 mg tablets sumatriptan Read all of this leaflet carefully before you start taking this medicine because

More information

IMMEDIATE DICLOFENAC NEW CONTRAINDICATIONS AND WARNINGS AFTER A EUROPE-WIDE REVIEW OF CARDIOVASCULAR SAFETY

IMMEDIATE DICLOFENAC NEW CONTRAINDICATIONS AND WARNINGS AFTER A EUROPE-WIDE REVIEW OF CARDIOVASCULAR SAFETY Finance, EHealth and Pharmaceuticals Directorate Pharmacy and Medicines Division T: 0131-244 2528 E: irene.fazakerley@scotland.gsi.gov.uk 1. Medical Directors 2. Directors of Public Health 3. Directors

More information

IMITREX UTILIZATION MANAGEMENT CRITERIA

IMITREX UTILIZATION MANAGEMENT CRITERIA IMITREX UTILIZATION MANAGEMENT CRITERIA DRUG CLASS: 5HT1 agonists BRAND NAME: Imitrex 4 mg injection kit or refill (Generic) (sumatriptan) 6 mg injection kit or refill Injection vial (1 dose) 5 mg nasal

More information

Clinical Policy: Sumatriptan Reference Number: CP.HNMC.260 Effective Date: Last Review Date: Line of Business: Medicaid Medi-Cal

Clinical Policy: Sumatriptan Reference Number: CP.HNMC.260 Effective Date: Last Review Date: Line of Business: Medicaid Medi-Cal Clinical Policy: Reference Number: CP.HNMC.260 Effective Date: 11.16.16 Last Review Date: 11.17 Line of Business: Medicaid Medi-Cal Revision Log See Important Reminder at the end of this policy for important

More information

Index. Prim Care Clin Office Pract 31 (2004) Note: Page numbers of article titles are in boldface type.

Index. Prim Care Clin Office Pract 31 (2004) Note: Page numbers of article titles are in boldface type. Prim Care Clin Office Pract 31 (2004) 441 447 Index Note: Page numbers of article titles are in boldface type. A Abscess, brain, headache in, 388 Acetaminophen for migraine, 406 407 headache from, 369

More information

Prevention and Treatment of Migraines CAITLIN BARNES, PHARM.D. CANDIDATE AMBULATORY CARE JOE CAMMILLERI, PHARM.D. NATOHYA MALLORY, PHARM.D.

Prevention and Treatment of Migraines CAITLIN BARNES, PHARM.D. CANDIDATE AMBULATORY CARE JOE CAMMILLERI, PHARM.D. NATOHYA MALLORY, PHARM.D. Prevention and Treatment of Migraines CAITLIN BARNES, PHARM.D. CANDIDATE AMBULATORY CARE JOE CAMMILLERI, PHARM.D. NATOHYA MALLORY, PHARM.D. Objectives Present patient case Review epidemiology/pathophysiology

More information

Ergotamine/Dihydroergotamine Products

Ergotamine/Dihydroergotamine Products Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the Company ), unless otherwise provided

More information

Recognition and treatment of medication overuse headache

Recognition and treatment of medication overuse headache Recognition and treatment of medication overuse headache Marcus Lewis MA, MRCGP, DRCOG, DFSRH 20 Mean weekly headache index 15 10 5 Medication overuse headache is a common condition responsible for a high

More information

SIGN 155 Pharmacological management of migraine. A national clinical guideline February Evidence

SIGN 155 Pharmacological management of migraine. A national clinical guideline February Evidence SIGN 155 Pharmacological management of migraine A national clinical guideline February 2018 Evidence KEY TO EVIDENCE STATEMENTS AND ECOMMENDATIONS LEVELS OF EVIDENCE High-quality meta-analyses, systematic

More information

Reducing the Impact of Migraine in the Workplace

Reducing the Impact of Migraine in the Workplace HEADACHE UK An alliance working for people with headache A Programme on behalf of Reducing the Impact of Migraine in the Workplace Content Outline of programme Background 3 Aim of programme Information

More information

Migranal Nasal Spray. Migranal Nasal Spray (dihydroergotamine) Description

Migranal Nasal Spray. Migranal Nasal Spray (dihydroergotamine) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.60 Subject: Migranal Nasal Spray Page: 1 of 5 Last Review Date: June 22, 2017 Migranal Nasal Spray

More information

Mid Essex Locality Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care

Mid Essex Locality Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care If possible patients should be assessed using a simple visual analogue scale VAS to determine the most appropriate stage

More information

Headache Questionnaire

Headache Questionnaire Date: All Headache Patients We would appreciate your cooperation in filling out this form. In our evaluation of headache, your history is typically our most valuable tool for diagnosis and subsequent treatment.

More information

M0BCore Safety Profile. Pharmaceutical form(s)/strength: ordispersible tablet SE/H/PSUR/0022/002 Date of FAR:

M0BCore Safety Profile. Pharmaceutical form(s)/strength: ordispersible tablet SE/H/PSUR/0022/002 Date of FAR: M0BCore Safety Profile Active substance: Zolmitriptan Pharmaceutical form(s)/strength: ordispersible tablet P-RMS: SE/H/PSUR/0022/002 Date of FAR: 15.03.2014 4.3 Contraindications Zolmitriptan is contraindicated

More information

I have no financial relationships to disclose. I will not discuss investigational use of medication in my presentation.

I have no financial relationships to disclose. I will not discuss investigational use of medication in my presentation. I have no financial relationships to disclose. I will not discuss investigational use of medication in my presentation. In 1962, Bille published landmark epidemiologic survey of headache among 9,000 school

More information

NI Formulary: Chapter 4 Central Nervous system

NI Formulary: Chapter 4 Central Nervous system Hypnotics Anxiolytics Acute state Non drug treatment Temazepam tablets 10mg, 20mg; oral solution 10mg/5ml or Zolpidem tablets 5mg, 10mg or Zopiclone 3.75mg, 7.5mg Non drug treatment Diazepam tablets 2mg,

More information

Understanding Migraines and Treatment Options. Simplified Diagnosis of Migraine. Migraine Prevalence American Migraine Study II

Understanding Migraines and Treatment Options. Simplified Diagnosis of Migraine. Migraine Prevalence American Migraine Study II Understanding Migraines and Treatment Options Deborah C. Zajac, RN-BC Center for Headache and Pain Neurological Institute Cleveland Clinic Simplified Diagnosis of Migraine Any person with a stable pattern

More information

2 What you need to know before you take Naramig

2 What you need to know before you take Naramig Package Leaflet: Information for the User Naramig 2.5 mg film-coated tablets naratriptan hydrochloride tablets for migraine Read all of this leaflet carefully before you start taking this medicine because

More information

Neurologic Disorders: Headache in Children

Neurologic Disorders: Headache in Children 1 of 12 17/06/2014 7:57 PM Print Close Neurologic Disorders: Headache in Children Sharon Whiting, MBBS, FRCPC Date of revision: February 2014 Headaches occur commonly in children and adolescents. They

More information

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Medical Policy An independent licensee of the Blue Cross Blue Shield Association CGRP Page 1 of 8 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: CGRP (calcitonin gene-related peptide) Prime Therapeutics will review Prior Authorization requests

More information

UTILIZATION MANAGEMENT CRITERIA

UTILIZATION MANAGEMENT CRITERIA SUMATRIPTAN (ALSUMA, IMITREX, SUMAVEL DOSEPRO, ZECUITY ) UTILIZATION MANAGEMENT CRITERIA DRUG CLASS: BRAND (generic) NAME: Serotonin 5-HT1 receptor agonists Imitrex (sumatriptan), Alsuma (sumatriptan),

More information

Drugs used for the treatment of pain Simple Analgesics Weak Opioids Strong Opioids Oral Strong Opioids Transdermal Strong Opioids Subcutaneous

Drugs used for the treatment of pain Simple Analgesics Weak Opioids Strong Opioids Oral Strong Opioids Transdermal Strong Opioids Subcutaneous Drugs used for the treatment of Simple Analgesics Weak Opioids Strong Opioids Oral Strong Opioids Transdermal Strong Opioids Subcutaneous Adjuvant analgesics Non Steroidal Anti-Inflammatory Drugs (NSAIDs)

More information

Migraine Management. Dr Helen Brown Director of Neurology and Stroke The Princess Alexandra Hospital

Migraine Management. Dr Helen Brown Director of Neurology and Stroke The Princess Alexandra Hospital Migraine Management Dr Helen Brown Director of Neurology and Stroke The Princess Alexandra Hospital Referral Criteria for Migraine Migraine Management Migraine Diagnosis Spot on Health Migraine pathway

More information

Your A-Z of Pain Relief A guide to pain relief medicines. We care, we discover, we teach

Your A-Z of Pain Relief A guide to pain relief medicines. We care, we discover, we teach Your A-Z of Pain Relief A guide to pain relief medicines We care, we discover, we teach Which pain medicines are you taking? Abstral (see Fentanyl Instant Tablets) Amitriptyline 5 Brufen (see Ibuprofen)

More information

MIGRAINE A MYSTERY HEADACHE

MIGRAINE A MYSTERY HEADACHE MIGRAINE A MYSTERY HEADACHE The migraine is a chronic neurological disease that is characterized by moderate to severe episodes of headache that is mostly associated with other central nervous system (CNS)

More information

10/31/2017 PRIMARY CARE AND HEADACHE DISCLOSURES WHERE DO THOSE WITH HEADACHE SEEK MEDICAL CARE? Primary Care 67%

10/31/2017 PRIMARY CARE AND HEADACHE DISCLOSURES WHERE DO THOSE WITH HEADACHE SEEK MEDICAL CARE? Primary Care 67% PRIMARY CARE AND HEADACHE Sonja Potrebic MD PhD Regional Headache Specialist Kaiser LAMC 1 WHERE DO THOSE WITH HEADACHE SEEK MEDICAL CARE? Column1 Primary Care 67% Primary Care Headache Specialty Other

More information

What is in this leaflet

What is in this leaflet Package leaflet: Information for the user 2.5 mg film-coated tablets Naratriptan Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

More information

CONSUMER MEDICINE INFORMATION

CONSUMER MEDICINE INFORMATION CONSUMER MEDICINE INFORMATION Arrow - Sumatriptan Sumatriptan (as succinate) 50 mg and 100 mg Tablets What is in this leaflet This leaflet answers some common questions about ARROW - SUMATRIPTAN. It does

More information

My patient s pain in the head, is a pain in Greg Jicha, M.D., Ph.D.

My patient s pain in the head, is a pain in Greg Jicha, M.D., Ph.D. My patient s pain in the head, is a pain in the @%$*&# Greg Jicha, M.D., Ph.D. Kentucky Neurologic Institute University of Kentucky, Lexington, KY Migraine is More Common than Asthma & Diabetes Combined

More information

Package leaflet: Information for the user. Zomig Rapimelt 2.5 mg orodispersible tablets zolmitriptan

Package leaflet: Information for the user. Zomig Rapimelt 2.5 mg orodispersible tablets zolmitriptan Package leaflet: Information for the user Zomig Rapimelt 2.5 mg orodispersible tablets zolmitriptan Read all of this leaflet carefully before you start taking this medicine because it contains important

More information

The best defense is a good offense. Optimizing the Acute Treatment of Migraine. Disclosures 11/10/2017

The best defense is a good offense. Optimizing the Acute Treatment of Migraine. Disclosures 11/10/2017 Optimizing the Acute Treatment of Migraine Brian M. Plato, DO, FAHS Norton Neuroscience Institute Louisville, KY Disclosures Speakers Bureau (personal): Allergan, Depomed, Avanir Research Funding (paid

More information

Ishaq Abu Arafeh Consultant Paediatrician Royal Hospital for Children, Glasgow Forth Valley Royal Hospital, Larbert

Ishaq Abu Arafeh Consultant Paediatrician Royal Hospital for Children, Glasgow Forth Valley Royal Hospital, Larbert Ishaq Abu Arafeh Consultant Paediatrician Royal Hospital for Children, Glasgow Forth Valley Royal Hospital, Larbert Childhood headache: Is it really difficult to manage? It shouldn t be... But it can be...

More information

Headache A Practical Approach

Headache A Practical Approach Headache A Practical Approach Integrated Pain Symposium December 1, 2017 Alyssa Lettich. MD Neurosciences Institute/Neurosciences Clinical Program Medical Director Headache and Pain Development Teams Disclosures:

More information

Current practice and future directions in the prevention and acute management of migraine

Current practice and future directions in the prevention and acute management of migraine Current practice and future directions in the prevention and acute management of migraine Peter J Goadsby, Till Sprenger Migraine is a common and disabling brain disorder with a strong inherited component.

More information

Berkshire West Area Prescribing Committee Guidance

Berkshire West Area Prescribing Committee Guidance Guideline Name Berkshire West Area Prescribing Committee Guidance Date of Issue: September 2015 Review Date: September 2017 Date taken to APC: 2 nd September 2015 Date Ratified by GP MOC: Guidelines for

More information